Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02103478
Title Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astex Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
University of Southern California Los Angeles California 90024 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Horizon Oncology Lafayette Indiana 47905 United States Details
Johns Hopkins Baltimore Maryland 21231 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
John Theurer Cancer Center/ Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Weill Cornell Medical College - New York Presbyterian Hospital New York New York 10021 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 United States Details
M. D. Anderson Houston Texas 77030 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
University of Alberta Hospital Edmonton Alberta T6G 2G3 Canada Details
Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto Ontario M4N 3M5 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
Hôpital Maisonneuve-Rosemont Montréal Quebec H1T 2M4 Canada Details
*Shaded cells indicate that there was no data available from for the field